Dechow T[au] - Search Results

Year	Number of Results
2000	1
2004	2
2006	3
2007	2
2008	3
2009	4
2010	7
2011	3
2012	4
2013	1
2014	4
2015	1
2016	2
2017	2
2018	1
2020	2
2021	7
2022	5
2023	5
2024	1

1

A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer.

Sahin U, Schuler M, Richly H, Bauer S, Krilova A, Dechow T, Jerling M, Utsch M, Rohde C, Dhaene K, Huber C, Türeci Ö. Sahin U, et al. Among authors: dechow t. Eur J Cancer. 2018 Sep;100:17-26. doi: 10.1016/j.ejca.2018.05.007. Epub 2018 Jun 21. Eur J Cancer. 2018. PMID: 29936063 Free article. Clinical Trial.

2

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).

Lorenzen S, Schwarz A, Pauligk C, Goekkurt E, Stocker G, Knorrenschild JR, Illerhaus G, Dechow T, Moehler M, Moulin JC, Pink D, Stahl M, Schaaf M, Goetze TO, Al-Batran SE. Lorenzen S, et al. Among authors: dechow t. BMC Cancer. 2023 Jun 19;23(1):561. doi: 10.1186/s12885-023-11004-z. BMC Cancer. 2023. PMID: 37337155 Free PMC article. Clinical Trial.

3

The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma.

Merz M, Dechow T, Scheytt M, Schmidt C, Hackanson B, Knop S. Merz M, et al. Among authors: dechow t. Ann Hematol. 2020 Aug;99(8):1709-1725. doi: 10.1007/s00277-020-04023-4. Epub 2020 Apr 16. Ann Hematol. 2020. PMID: 32296915 Free PMC article. Review.

4

Monitoring response to therapeutic interventions in patients with cancer.

Herrmann K, Krause BJ, Bundschuh RA, Dechow T, Schwaiger M. Herrmann K, et al. Among authors: dechow t. Semin Nucl Med. 2009 May;39(3):210-32. doi: 10.1053/j.semnuclmed.2008.12.001. Semin Nucl Med. 2009. PMID: 19341841 Review.

5

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyögg J. Buck AK, et al. Among authors: dechow t. J Nucl Med Technol. 2010 Mar;38(1):6-17. doi: 10.2967/jnmt.108.059584. J Nucl Med Technol. 2010. PMID: 20197541 Free article. Review.

6

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyögg J. Buck AK, et al. Among authors: dechow t. J Nucl Med. 2010 Mar;51(3):401-12. doi: 10.2967/jnumed.108.059584. Epub 2010 Feb 11. J Nucl Med. 2010. PMID: 20150250 Free article. Review.

7

Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.

Muendlein A, Heinzle C, Brandtner EM, Leiherer A, Geiger K, Gaenger S, Drexel H, Dechow T, Decker T. Muendlein A, et al. Among authors: dechow t. Breast Cancer Res Treat. 2023 Oct;201(3):571-576. doi: 10.1007/s10549-023-07045-4. Epub 2023 Jul 25. Breast Cancer Res Treat. 2023. PMID: 37490173

8

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.

Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K, Drexel H, Winder T, Reimann P, Mayer F, Nonnenbroich C, Dechow T. Muendlein A, et al. Among authors: dechow t. Front Oncol. 2022 Oct 24;12:1045995. doi: 10.3389/fonc.2022.1045995. eCollection 2022. Front Oncol. 2022. PMID: 36353562 Free PMC article.

9

Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer.

Muendlein A, Heinzle C, Brandtner EM, Leiherer A, Drexel H, Dechow T, Decker T. Muendlein A, et al. Among authors: dechow t. Oncol Res Treat. 2023;46(4):151-156. doi: 10.1159/000529547. Epub 2023 Feb 7. Oncol Res Treat. 2023. PMID: 36750040 Free article.

10

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.

Muendlein A, Geiger K, Heinzle C, Gaenger S, Winder T, Severgnini L, Reimann P, Brandtner EM, Leiherer A, Drexel H, Decker T, Nonnenbroich C, Dechow T. Muendlein A, et al. Among authors: dechow t. J Cancer Res Clin Oncol. 2023 Aug;149(9):6435-6444. doi: 10.1007/s00432-023-04623-3. Epub 2023 Feb 10. J Cancer Res Clin Oncol. 2023. PMID: 36763171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year